延胡索酸酯治疗银屑病研究进展

China Journal of Leprosy and Skin Diseases ›› 2018, Vol. 34 ›› Issue (6): 370-373.

Previous Articles Next Articles

Update of fumaric acid esters for treating psoriasis

ZENG Jingxin 1,2 , Zhang Lidan1,2, Liu Weiyv1,2, LUO Quan2

1. Guangzhou Institute of Dematology, Guangzhou 510095, China 2. Guangzhou Medical University, Guangzhou 510182, China

Online:2018-06-15 Published:2018-12-11
Contact: LUO Quan, E-mail: luoquan666@126.com

Abstract

ZENG Jingxin , , Zhang Lidan, Liu Weiyv, LUO Quan. Update of fumaric acid esters for treating psoriasis[J].China Journal of Leprosy and Skin Diseases, 2018, 34(6): 370-373.

[1]	ZHU Jingna, MO Huihui, LIANG Yanhua. Fluorescent staining to identify fungal cloning in the healthy skin and inflammatory lesions [J]. China Journal of Leprosy and Skin Diseases, 2022, 38(2): 83-88.
[2]	ZHOU Xiaonan, GAO Yingxia, CAO Chunyan, WANG Fang, YANG Zhengqian. Effect of therapeutic games based on Satya model on hospitalized children with psoriasis and their parents [J]. China Journal of Leprosy and Skin Diseases, 2022, 38(2): 122-127.
[3]	LIU Chengling, HE Zan, REN Dan, WANG Jingyu, DU Zhimin, SUN Yufa, ZHAO Hua. Association of psoriasis and psoriatic arthritis with ulcerative colitis: a meta-analysis [J]. China Journal of Leprosy and Skin Diseases, 2022, 38(1): 8-13.
[4]	WANG Juanjuan, YIN Xingping, SUN Linan, GAO Yuan, LU Xiaojun, LIU Wei. Psoriasis complicated with arsenate keratosis: a case report [J]. China Journal of Leprosy and Skin Diseases, 2022, 38(1): 51-53.
[5]	SUN Weina, LI Yuzhen. Update of treatment for erythrodermic psoriasis [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(9): 614-617.
[6]	REN Guohua, ZHAO Ying. Effects of total glucosides of paeony combined with NB-UVB on the expression of serum IL-17, IL-23 and lesion PAR-2 in patients with moderate to severe psoriasis [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(8): 506-509.
[7]	HU Zhonghui, SUN Qing. Update of biological agents in the treatment of psoriasis comorbidities [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(7): 471-476.
[8]	LOU Yanfeng, ZHOU Xiaowei, LIU Fang, KONG Qingtao, CHEN Jun, YANG Yang. Analysis of relapsing factors in psoriasis vulgaris and study on self-management intervention [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(6): 376-379.
[9]	SUN Jie, WANG Rui, HUANG Min, BAI Jia, LI Chengxin. Effect of IL-17A on insulin resistance in keratinocytes [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(5): 271-275.
[10]	HAN Lu, ZHOU Yang, DUAN Xingwu, CHEN Bing, FANG Ru'nan, LI Jianhong. Animal experimental study on the mechanism of Xiaoyinjiedu Decoction inhibiting keratinocyte proliferation through cdc7 [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(3): 148-152.
[11]	XIE Hui, NIU Meili, WANG Xinhui, LIU Qu, MIAO Guoying. Assessment of the efficacy of Secukinumab in the treatment of six cases of childhood psoriasis [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(3): 157-159.
[12]	ZHANG Zhiqin, TU Jie, YIN Zhiqiang. The effect of psoriasis on reproduction and pregnancy [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(3): 176-179.
[13]	KONG Zelin, JIAO Tiantian, ZHANG Furen. The related factors of psoriasis complicated with type 2 diabetes [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(2): 80-84.
[14]	WANG Youlin, WANG Rui, ZHAO Zhenkai, SUN Jie, ZHANG Yuan, TANG Zijie, ZHANG Han, SHU Xin, LI Chengxin. Efficacy of adalimumab in the treatment of plaque psoriasis with or without metabolic syndrome [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(12): 755-758.
[15]	ZHU Beibei, LIU Yi, LI Jing, HUAN Jing, NI Qi, YANG Xueyuan. Quality assessment of clinical trials in psoriasis, 2016-2020 [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(12): 779-782.

Update of fumaric acid esters for treating psoriasis

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 10